Search Results - "Cosgriff, T."

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC by Knox, J.J., Barrios, C.H., Kim, T.M., Cosgriff, T., Srimuninnimit, V., Pittman, K., Sabbatini, R., Rha, S.Y., Flaig, T.W., Page, R.D., Beck, J.T., Cheung, F., Yadav, S., Patel, P., Geoffrois, L., Niolat, J., Berkowitz, N., Marker, M., Chen, D., Motzer, R.J.

“…RECORD-3 compared everolimus and sunitinib as first-line therapy, and the sequence of everolimus followed by sunitinib at progression compared with the…”
Get full text

Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4) by Motzer, R.J., Alyasova, A., Ye, D., Karpenko, A., Li, H., Alekseev, B., Xie, L., Kurteva, G., Kowalyszyn, R., Karyakin, O., Neron, Y., Cosgriff, T., Collins, L., Brechenmacher, T., Lin, C., Morgan, L., Yang, L.

“…RECORD-1 demonstrated clinical benefit of everolimus in patients with metastatic renal cell carcinoma (mRCC) previously treated with sunitinib, sorafenib, or…”
Get full text

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC by Knox, J J, Barrios, C H, Kim, T M, Cosgriff, T, Srimuninnimit, V, Pittman, K, Sabbatini, R, Rha, S Y, Flaig, T W, Page, R D, Beck, J T, Cheung, F, Yadav, S, Patel, P, Geoffrois, L, Niolat, J, Berkowitz, N, Marker, M, Chen, D, Motzer, R J

Get full text

2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis by Alekseev, B, Yang, L, Alyasova, A, Ye, D, Karpenko, A, Li, H, Xie, L, Kurteva, G, Kowalyszyn, R, Karyakin, O, Neron, Y, Cosgriff, T, Collins, L, Brechenmacher, T, Lin, J, Morgan, L, Motzer, R

Get full text

2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis by Yang, L, Alyasova, A, Ye, D, Karpenko, A, Li, H, Alekseev, B, Xie, L, Kurteva, G, Kowalyszyn, R, Karyakin, O, Neron, Y, Cosgriff, T, Collins, L, Brechenmacher, T, Lin, J, Morgan, L, Motzer, R

Get full text

Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC) by Hirsch, F.R, Govindan, R, Zvirbule, Z, Braiteh, F, Rittmeyer, A, Belda Iniesta, C, Isla, D, Cosgriff, T, Boyer, M, Ueda, M, Phan, S, Gandara, D

Get full text

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC): Results From a Phase 2, Placebo-Controlled Study (GO27821) by Wakelee, H.A, Zvirbule, Z, De Braud, F, Kingsley, C.D, Mekhail, T, Schütte, W, Lena, H, Lawler, W, Braiteh, F, Cosgriff, T, Kaen, D, Boyer, M, Hsu, J, Phan, S, Novello, S

Get full text

Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer by Chong, G., Bhatnagar, A., Cunningham, D., Cosgriff, T. M., Harper, P. G., Steward, W., Bridgewater, J., Moore, M., Cassidy, J., Coleman, R., Coxon, F., Redfern, C. H., Jones, J. J., Hawkins, R., Northfelt, D., Sreedharan, S., Valone, F., Carmichael, J.

“…Background: The monoclonal antibody 3H1 mimics the external structure of the carcinoembryonic antigen (CEA). It therefore has the potential, via the…”
Get full text

Hemorrhagic fever virus-induced changes in hemostasis and vascular biology by Chen, J P, Cosgriff, T M

“…Viral hemorrhagic fever (VHF) denotes a virus-induced acute febrile, hemorrhagic disease reported from wide areas of the world. Hemorrhagic fever (HF) viruses…”
Get full text

Abstract CT129: Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in NSCLC involving the CNS by Weiner, Roy S., Mahmood, T, Gordon, C, Ware, ML, Morgan, LR, Cosgriff, TM, Rodgers, AH, Bastian, G, Kawauchi, R, Matrana, M, Zou, J-J

“…Abstract Background: 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) is a poly-chlorinated pyridine cholesteryl carbonate with a MOA via…”
Get full text

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome by Huggins, John W., Hsiang, Chin Min, Cosgriff, Thomas M., Guang, Mei Ying, Smith, Joseph I., Wu, Zhen Ou, LeDuc, James W., Zheng, Zhi Ming, Meegan, James M., Wang, Qi Nan, Oland, Dwayne D., Gui, Xi En, Gibbs, Paul H., Yuan, Guang Hui, Zhang, Tian Ming

“…A prospective, randomized, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin (loading dose of 33 mg/kg, 16 mg/kg every 6 h…”
Get full text

Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicin by Cosgriff, Thomas M., Black, Marcus L., Stein, William

“…Idiopathic thrombocytopenic purpura (ITP) is refractory to initial treatment (steroids and splenectomy) in 25 to 30% of patients. These patients have a…”
Get full text

Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC by Knox, J.J., Barrios, C.H., Kim, T.M., Cosgriff, T., Srimuninnimit, V., Pittman, K., Sabbatini, R., Rha, S.Y., Flaig, T.W., Page, R.D., Beck, J.T., Cheung, F., Yadav, S., Patel, P., Geoffrois, L., Niolat, J., Berkowitz, N., Marker, M., Chen, D., Motzer, R.J.

Get full text

Pathogenesis of Rift Valley fever in rhesus monkeys : role of interferon response by MORRILL, J. C, JENNINGS, G. B, JOHNSON, A. J, COSGRIFF, T. M, GIBBS, P. H, PETERS, C. J

“…Rhesus monkeys inoculated intravenously with Rift Valley fever (RVF) virus presented clinical disease syndromes similar to human cases of RVF. All 17 infected…”
Get full text

Pulmonary edema in falciparum malaria. Slaying the dragon of volume overload by Cosgriff, T M

Get more information

Hemorrhagic fever with renal syndrome: four decades of research by Cosgriff, T M

“…Hemorrhagic fever with renal syndrome is an acute infectious illness characterized by fever, hemorrhage, and renal failure. Research over the last 40 years has…”
Get more information

Mechanisms of disease in hemorrhagic fever with renal syndrome by Cosgriff, T M, Lewis, R M

“…Hemorrhagic fever with renal syndrome (HFRS) is a dramatic illness characterized by fever, and variable degrees of circulatory failure, hemorrhage, and renal…”
Get more information

Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC): Metastatic Non-Small Cell Lung Cancer by Hirsch, F.R., Govindan, R., Zvirbule, Z., Braiteh, F., Rittmeyer, A., Belda Iniesta, C., Isla, D., Cosgriff, T., Boyer, M., Ueda, M., Phan, S., Gandara, D.

Get full text

Safety and immunogenicity of a Plasmodium vivax sporozoite vaccine by Gordon, D M, Cosgriff, T M, Schneider, I, Wasserman, G F, Majarian, W R, Hollingdale, M R, Chulay, J D

“…A recombinant DNA Plasmodium vivax sporozoite vaccine containing the repeating region of the Salvador I strain circumsporozoite (CS) protein was produced in…”
Get more information

Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum by Chulay, J D, Schneider, I, Cosgriff, T M, Hoffman, S L, Ballou, W R, Quakyi, I A, Carter, R, Trosper, J H, Hockmeyer, W T

“…Malaria was transmitted to six normal human volunteers by mosquitoes infected from cultured gametocytes of Plasmodium falciparum. This method, which offers…”
Get more information